Celsion Corporation to Hold Year-End 2019 Financial Results Conference Call on Thursday, March 26, 2020  Company to Provide Update on its Phase III OPTIMA Study in Primary Liver Cancer and its Phase I/II OVATION 2 Study in Ovarian Cancer LAWRENCEVILLE, N.J., March 19, 2020 (GLOBE NEWSWIRE) -- Celsion...